VAXART INC. - COMMON STOCK
0.4497
02-May-25 16:45:00
15 minutes delayed
Stocks
+0.0211
+4.92%
Today's range
0.4273 - 0.4600
ISIN
N/A
Source
NASDAQ
-
02 Dec 2024 16:01:00 By Nasdaq GlobeNewswire
-
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
13 Nov 2024 16:01:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
24 Oct 2024 08:00:01 By Nasdaq GlobeNewswire
-
15 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 16:12:22 By Nasdaq GlobeNewswire
-
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
Vaxart Provides Business Update and Reports Second Quarter 2024 Financial Results
08 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
02 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
Vaxart Provides Business Update
17 Jun 2024 16:05:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: VAXART INC. - COMMON STOCK
17 Jun 2024 15:51:57 By NetDania Notify
-
Vaxart Announces $40 Million Underwritten Offering of Common Stock
13 Jun 2024 19:07:26 By Nasdaq GlobeNewswire
-
13 Jun 2024 16:15:11 By Nasdaq GlobeNewswire
-
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
13 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
07 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
30 Apr 2024 08:00:39 By Nasdaq GlobeNewswire
-
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
27 Mar 2024 08:00:00 By Nasdaq GlobeNewswire